Boehringer In­gel­heim files suit to block drug price ne­go­ti­a­tions. Is the fight ul­ti­mate­ly head­ed for the Supreme Court?

Boehringer In­gel­heim is the lat­est phar­ma­ceu­ti­cal com­pa­ny to sue the fed­er­al gov­ern­ment over the In­fla­tion Re­duc­tion Act in a fight some drug pric­ing ex­perts say …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER